Prelude Therapeutics Balance Sheet (2024-2025) | PRLD

Balance Sheet Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 28.75M31.87M15.18M16.52M103.10M77.30M58.20M
Short-term Investments 177.22M152.02M142.49M121.14M58.80M47.46M7.42M
Cash & Current Investments 205.97M183.89M157.67M137.66M161.91M124.76M65.62M
Prepaid Assets 3.44M2.87M2.76M2.28M3.33M3.66M3.37M
Current Assets 205.37M182.71M156.39M135.90M102.40M76.88M58.33M
Non-Current Assets
Property, Plant & Equipment (Net) 7.29M7.55M7.20M6.77M6.39M5.96M5.53M
Other Non-Current Assets 4.04M4.04M4.04M4.04M4.04M4.04M3.23M
Non-Current Assets 41.74M41.58M40.83M39.62M38.86M38.04M36.42M
Assets 247.11M224.29M197.22M175.51M141.26M114.92M94.75M
Liabilities
Current Liabilities
Accounts Payables 5.31M6.17M5.92M7.73M5.83M4.96M2.53M
Payables 5.31M6.17M5.92M7.73M5.83M4.96M2.53M
Accumulated Expenses 10.15M11.43M13.58M15.21M11.30M13.23M12.93M
Other Accumulated Expenses 0.80M0.46M0.80M0.77M0.70M0.86M0.96M
Current Leases 2.19M2.23M2.37M2.49M2.60M2.71M2.73M
Current Deferred Revenue 3.00M
Total Current Liabilities 17.64M23.34M22.22M25.64M19.79M20.91M18.19M
Non-Current Liabilities
Operating Leases 15.45M18.20M18.14M15.32M15.27M15.21M15.13M
Other Non-Current Liabilities 3.28M3.21M3.15M3.09M3.03M2.97M2.90M
Total Non-Current Liabilities 33.09M38.80M37.64M40.97M35.05M36.11M33.32M
Total Liabilities 36.37M42.02M40.79M44.06M38.08M39.08M36.22M
Shareholder's Equity
Common Equity 210.73M182.28M156.43M131.46M103.18M75.84M58.53M
Shareholder's Equity 210.73M182.28M156.43M131.46M103.18M75.84M58.53M
Liabilities and Shareholders Equity 247.11M224.29M197.22M175.51M141.26M114.92M94.75M
Retained Earnings -487.82M-522.60M-554.83M-583.56M-615.65M-646.90M-666.60M
Treasury Shares 0.09M0.08M0.07M0.06M0.38M0.34M0.29M